CJC-1295

Q: What is the typical dosage for CJC-1295?

The typical dosage is 100–200 mcg, administered via Subcutaneous injection.

Q: What is the half-life of CJC-1295?

The half-life of CJC-1295 is ~30 minutes (no DAC).

Q: Is CJC-1295 FDA approved?

No, CJC-1295 is currently classified as "Research" and is not FDA approved for general use.

Also known as: Mod GRF(1-29) · Modified GRF · CJC-1295 no DAC

A modified GHRH analog that delivers intense, acute GH spikes mimicking natural nocturnal pulses. Almost always stacked with Ipamorelin for synergistic, non-suppressive GH release.

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~30 minutes (no DAC)

Typical Dose

100–200 mcg

Administration

Subcutaneous injection

Mechanism of Action

Binds GHRH receptors on pituitary somatotrophs, amplifying natural GH pulses when paired with a GHRP. The no-DAC version avoids continuous GH elevation.

Key Research Areas

growth hormoneGHRHipamorelin stackanti-aging

Frequently Asked Questions

What is CJC-1295?▾

A modified GHRH analog that delivers intense, acute GH spikes mimicking natural nocturnal pulses. Almost always stacked with Ipamorelin for synergistic, non-suppressive GH release.

How does CJC-1295 work?▾

Binds GHRH receptors on pituitary somatotrophs, amplifying natural GH pulses when paired with a GHRP. The no-DAC version avoids continuous GH elevation.

What is the recommended dosage for CJC-1295?▾

The typical research dosage is 100–200 mcg, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.

What is the half-life of CJC-1295?▾

The half-life of CJC-1295 is approximately ~30 minutes (no DAC). This affects dosing frequency and timing in research protocols.

Is CJC-1295 FDA approved?▾

CJC-1295 is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about CJC-1295 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Growth Hormone

MK-677

Ibutamoren · MK677

Sermorelin

GRF 1-29 · Geref

Ipamorelin

NNC 26-0161

Tesamorelin

Egrifta

Back to All Peptides Find Your Peptide — Take the Quiz